Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Discovery Lifts 2027 Medical Aid Fees 8.2% on Average

Discovery will raise contributions by 8.2% and Momentum by 7.9% from January 2027, both far above the regulator's 3.8% anchor. The post Discovery Lifts 2027 Medical Aid Fees 8.2% on Average appeared first on The Rio Times .

Two of South Africa’s largest medical schemes, Discovery Health Medical Scheme (DHMS) and Momentum, announced 2027 contribution increases far exceeding the Council for Medical Schemes (CMS) regulatory anchor of 3.8%. DHMS plans an average 8.2% increase from January 2027, while Momentum will see an average 7.9% rise. Both proposals require regulator approval.

DHMS’ increases range from 7.4% to 8.9%, depending on the specific plan. Certain plans, like KeyCare, Coastal Core, Priority, Comprehensive, Executive, and Active Smart, will face the full 8.9% rise. The CMS anchor serves as guidance, allowing schemes to add a reasonable allowance for healthcare costs. DHMS argues its increase is 2.5 percentage points below what it required, positioning itself as relatively restrained compared to the next six largest open schemes.

The increases primarily reflect medical-cost inflation, provider pricing, and aging risk pools rather than headline consumer inflation. The dispute highlights the contest between private healthcare capital and the state over financing essential services. Members facing the highest increases, like the 8.9% proposal for KeyCare and Executive plans, will notice immediate impacts on monthly premiums starting January 2027.

Written by urgent.news from The Rio Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at riotimesonline.com →

More in Health & Medicine

Vaccine Myths and Misinformation

Immunizations, or vaccines as they’re also known, safely and effectively use a small amount of a weakened or killed virus or bacteria or bits of lab-made protein that imitate the virus in order to…

Bereum Secures FDA, Journal, Patents

Bereum Co., Ltd. (CEO Han Kwon-il), a company specializing in postbiotics, has fully kick-started its campaign to capture the global healthcare market, spearheaded by its kimchi-derived proprietary…

  • Bereum's proprietary strain beLP1® registered as FDA New Dietary Ingredient.
  • Double-blind study in Frontiers in Nutrition shows beLP1® reduces gastrointestinal symptoms.
  • Bereum secures patents for anti-stress and obesity improvement compositions.

More from Friday 2 October →